Filing Details
- Accession Number:
- 0001209191-21-046210
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-09 17:10:15
- Reporting Period:
- 2021-05-18
- Accepted Time:
- 2021-07-09 17:10:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1408500 | E Martin Cearnal | 2525 West End Ave. Suite 950 Nashville TN 37203 | Sr Vp/Chief Commercial Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-05-18 | 105 | $2.91 | 161,904 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-19 | 105 | $2.83 | 162,009 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-20 | 105 | $2.94 | 162,114 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-21 | 105 | $3.06 | 162,219 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-24 | 105 | $3.02 | 162,324 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-25 | 105 | $2.89 | 162,429 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-26 | 105 | $2.85 | 162,534 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-27 | 105 | $2.94 | 162,639 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-28 | 105 | $2.93 | 162,744 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-06-01 | 105 | $2.94 | 162,849 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-06-02 | 105 | $2.89 | 162,954 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-06-03 | 105 | $2.81 | 163,059 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-06-04 | 105 | $2.93 | 163,164 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-06-07 | 105 | $2.94 | 163,269 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-06-08 | 105 | $2.99 | 163,374 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-06-09 | 105 | $3.14 | 163,479 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-06-10 | 105 | $3.25 | 163,584 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-06-11 | 105 | $3.18 | 163,689 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-06-14 | 105 | $3.11 | 163,794 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-06-15 | 105 | $3.09 | 163,899 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-06-16 | 105 | $3.09 | 164,004 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-06-17 | 105 | $3.08 | 164,109 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-06-18 | 105 | $2.99 | 164,214 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-06-21 | 105 | $3.14 | 164,319 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-06-22 | 105 | $3.05 | 164,424 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-06-23 | 105 | $3.07 | 164,529 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-06-24 | 105 | $3.09 | 164,634 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-06-25 | 105 | $3.09 | 164,739 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-06-28 | 105 | $3.16 | 164,844 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-06-29 | 105 | $3.03 | 164,949 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.